DCVC Bio Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 3
Professionals
  • Investments
  • 33
  • Portfolio
  • 21
  • Exits
  • 5
Exits

DCVC Bio General Information

Description

Founded in 2018, DCVC Bio is a venture capital firm based in San Francisco, California. The firm backs entrepreneurs applying deep technologies powering new industries and revitalizing old ones. The firm invests in early-stage companies that address challenges in human health, agriculture and industrial biotechnology.

Contact Information

Formerly Known As
Monsanto Growth Ventures (MGV)
Year Founded
2018
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 500 2nd Street
  • Suite 200
  • San Francisco, CA 94107
  • United States

DCVC Bio Investments (33)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Creyon Bio 08-Mar-2022 Early Stage VC 0000 Drug Discovery Pre-Clinical Trials 00000000 00000 00.0
0000000 23-Feb-2022 00000 00000 00000 Drug Discovery Generating Revenue 00000000 00000 00.0
0000000 00000000 22-Feb-2022 00000 00000 0000 Machinery (B2B) Generating Revenue 00000000 00000 00.0
00000 000000000 09-Dec-2021 00000 00000 0000 Discovery Tools (Healthcare) Startup 0000 00000 00.0
000 000000 01-Nov-2021 00000 00000 0000 Environmental Services (B2B) Generating Revenue 0000 00000 00.0
0000000 0000000000 15-Jul-2021 00000 00000 000.00 Biotechnology Pre-Clinical Trials 00000000 00000 00.0
00000000 000000000 25-Jun-2021 00000 00000 000.00 Drug Discovery Pre-Clinical Trials
00000 000000000 15-Jun-2021 00000 00000 00000 Drug Discovery Pre-Clinical Trials 0000 00000 00.0
BioPhero 09-Mar-2021 Later Stage VC 000.00 Agricultural Chemicals Generating Revenue 0000 00000 00.0
Plexium 21-Jan-2021 Early Stage VC 0000 Drug Discovery Generating Revenue 00000000 00000 00.0
You’re viewing 10 of 33 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DCVC Bio Exits (5)

Company Name Exit Date Exit Type Exit Size
SentinelOne 30-Jun-2021 IPO 00.000
00000000 22-Apr-2021 000 00000
Recursion 16-Apr-2021 IPO 00000
AbCellera 11-Dec-2020 IPO 00000
You’re viewing 4 of 5 exits. Get the full list »

DCVC Bio Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore DCVC Bio‘s full profile, request access.

Request a free trial

DCVC Bio Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

DCVC Bio Team (6)

Name Title Deals Funds Boards Office
John Hamer Ph.D Managing Partner 00 0 00 San Francisco, CA
Kiersten Stead Ph.D Managing Partner 00 0 0 San Francisco, CA
Andy May Entrepreneur-in-Residence San Francisco, CA
Christopher Meldrum Entrepreneur-in-Residence 0 0 San Francisco, CA
Anna Fokina Investment Director San Francisco, CA
You’re viewing 5 of 6 team members. Get the full list »

DCVC Bio Co-Investors (127)

Name With Exits Lead Partner Series Industry
DCVC 4 0 Series chart Industry bar
8VC 0 0 Series chart Industry bar
Alexandria Venture Investments 0 0 Series chart Industry bar
Neotribe Ventures 0 0 Series chart Industry bar
Lux Capital 0 0 Series chart Industry bar
You’re viewing 5 of 127 co-investors. Get the full list »